Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Hemorrhagic Disorders
Description
Spontaneous or near spontaneous bleeding caused by a defect in clotting mechanisms (BLOOD COAGULATION DISORDERS) or another abnormality causing a structural flaw in the blood vessels (HEMOSTATIC DISORDERS). MeSH
Hierarchy View
Subtype Terms (21)
Afibrinogenemia
2 drugs (1 approved, 1 experimental)
Disseminated Intravascular Coagulation
10 drugs (7 approved, 3 experimental)
Factor VII Deficiency
6 drugs (2 approved, 4 experimental)
Factor X Deficiency
1 approved drug
Factor XI Deficiency
1 approved drug
Factor XIII Deficiency
1 approved drug
Hemophilia A
88 drugs (42 approved, 46 experimental)
Hemophilia B
46 drugs (16 approved, 30 experimental)
Hemostatic Disorders
4 drugs (1 approved, 3 experimental)
Hypoprothrombinemias
2 approved drugs
Platelet Storage Pool Deficiency
6 approved drugs
Purpura, Thrombocytopenic, Idiopathic
78 drugs (53 approved, 25 experimental)
Thrombasthenia
10 drugs (8 approved, 2 experimental)
Thrombocythemia, Essential
65 drugs (41 approved, 24 experimental)
Vitamin K Deficiency
5 drugs (3 approved, 2 experimental)
von Willebrand Diseases
14 drugs (7 approved, 7 experimental)
Waterhouse-Friderichsen Syndrome
Wiskott-Aldrich Syndrome
34 drugs (24 approved, 10 experimental)
Phase 4 Indicated Drugs (1)
Phase 3 Indicated Drugs (1)
Phase 2 Indicated Drugs (2)
Phase 1 Indicated Drugs (5)
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (10)
Organization Involved with Phase 2 Indications (4)
Organization Involved with Phase 1 Indications (1)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
